MD Esthetics

MD Esthetics, LLC specializes in aesthetic treatments that enhance natural beauty through injectables, skin rejuvenation therapies, and body contouring solutions, serving clients across various regions in the US. Founded in 2018 in Windham, US, MD Esthetics focuses on aesthetic procedures. The company has engaged in one deal, with its most recent transaction occurring on May 1, 2025, when New Harbor Capital invested in the firm. Financial details of the investment were not disclosed.

MD Esthetics offers a range of aesthetic treatments aimed at enhancing natural beauty. Their core services include neurotoxin injections like Botox and Dysport, dermal fillers such as Kybella and Sculptra, and advanced skin treatments including microneedling, chemical peels, and laser therapies. The company caters to various skincare needs, focusing on anti-aging, acne prevention, and body sculpting. They serve clients across the northeastern United States, specifically in New Hampshire, Massachusetts, and Virginia, including Virginia Beach and other locations.

MD Esthetics generates revenue through a direct-to-consumer model for aesthetic procedures and treatments, which are typically purchased on a per-session basis or via membership plans. They implement various pricing structures, including promotional discounts for specific services to encourage client engagement and loyalty. Additionally, membership programs provide ongoing access to treatments at preferential rates, contributing to a steady income stream for the company. Following its investment on May 1, 2025, from New Harbor Capital, MD Esthetics plans to use the funding to expand its service offerings and enhance its technology.

The company aims to launch new products and services in the near future and is exploring opportunities for geographic expansion into new markets.